Eledon Pharmaceuticals to Present at Ladenburg Thalmann Healthcare Conference

Rhea-AI Summary

Eledon Pharmaceuticals (NASDAQ: ELDN) announced that CEO David-Alexandre C. Gros will participate in a fireside chat at the Ladenburg Thalmann Healthcare Conference on September 29, 2022, at 2:00 p.m. ET in New York City. Interested parties can register for the webcast here. A replay will be available afterward on the company’s website.

Eledon specializes in developing treatments targeting the CD40 Ligand pathway for transplant patients and those with autoimmune diseases.

IRVINE, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that David-Alexandre C. Gros, Chief Executive Officer, will participate in a fireside chat at the Ladenburg Thalmann Healthcare Conference on Thursday, September 29, 2022 at 2:00 p.m. ET in New York City.

To register in advance for the fireside chat webcast, sign up here.

A webcast replay will be accessible following the live session on the Events page of the Investors section on the Company’s website at https://ir.eledon.com/events-and-presentations/events.

About Eledon Pharmaceuticals and tegoprubart (formerly AT-1501)

Eledon Pharmaceuticals is a clinical stage biotechnology company using its expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop potential treatments for persons requiring an organ or cell-based transplant, living with autoimmune disease, or living with ALS. The company’s lead compound in development is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand, a well-validated biological target with broad therapeutic potential. Eledon is headquartered in Irvine, Calif. For more information, please visit the company’s website at www.eledon.com.

Follow Eledon Pharmaceuticals on social media: LinkedIn; Twitter

Investor Contact:

Stephen Jasper
Gilmartin Group
(858) 525-2047
stephen@gilmartinir.com

FAQ

What event will Eledon Pharmaceuticals participate in on September 29, 2022?

Eledon Pharmaceuticals will participate in the Ladenburg Thalmann Healthcare Conference.

When is the Eledon Pharmaceuticals fireside chat scheduled?

The fireside chat is scheduled for September 29, 2022, at 2:00 p.m. ET.

How can I register for the Eledon Pharmaceuticals webcast?

You can register for the Eledon Pharmaceuticals webcast by signing up here.

Where can I find the replay of the Eledon Pharmaceuticals webcast?

The replay of the Eledon Pharmaceuticals webcast will be available on the company’s Events page.

What therapeutic focus does Eledon Pharmaceuticals have?

Eledon Pharmaceuticals focuses on developing treatments targeting the CD40 Ligand pathway for transplant needs and autoimmune diseases.